Interacting Drugs |
Amlodipine and atorvastatin vs Dabigatran Etexilate |
Security Level |
|
Mechanism |
Dabigatran Etexilate: Atorvastatin may decrease the serum concentration of Dabigatran Etexilate. |
Management |
Monitor therapy |
Amlodipine and atorvastatin vs Dabigatran Etexilate
Post Review about Amlodipine and atorvastatin vs Dabigatran Etexilate Click here to cancel reply.
Other Interactions of Amlodipine and atorvastatin
Other Interactions of Dabigatran Etexilate
Amlodipine and atorvastatin vs Dabigatran Etexilate
Interacting Drugs |
Amlodipine and atorvastatin vs Dabigatran Etexilate |
Security Level |
|
Mechanism |
Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate. |
Management |
Dabigatran dose reductions may be needed. According to Canadian labeling, dabigatran dose for prevention of venous thromboembolism post hip or knee replacement should be reduced to 150 mg/day in patients receiving amiodarone, verapamil, or quinidine. |
No comments yet.
Post Review about Amlodipine and atorvastatin vs Dabigatran Etexilate Click here to cancel reply.
Other Interactions of Amlodipine and atorvastatin
Other Interactions of Dabigatran Etexilate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.